These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18835440)

  • 21. To die or not to die: neurons and p63.
    Miller FD; Kaplan DR
    Cell Cycle; 2007 Feb; 6(3):312-7. PubMed ID: 17264677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour suppression by p53: the importance of apoptosis and cellular senescence.
    Zuckerman V; Wolyniec K; Sionov RV; Haupt S; Haupt Y
    J Pathol; 2009 Sep; 219(1):3-15. PubMed ID: 19562738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulation of p53 function and promoter selectivity by post-translational modifications].
    Tanaka T
    Seikagaku; 2010 Mar; 82(3):200-9. PubMed ID: 20408452
    [No Abstract]   [Full Text] [Related]  

  • 24. Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2.
    Bitomsky N; Hofmann TG
    FEBS J; 2009 Nov; 276(21):6074-83. PubMed ID: 19788416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the study of p53 in response to DNA damage].
    Wang YJ; Sun H; Liu GT; Chen XG
    Yao Xue Xue Bao; 2011 Dec; 46(12):1413-9. PubMed ID: 22375412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant p53 mediates survival of breast cancer cells.
    Lim LY; Vidnovic N; Ellisen LW; Leong CO
    Br J Cancer; 2009 Nov; 101(9):1606-12. PubMed ID: 19773755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The p53 homology trap.
    Knight RA; Candi E; Melino G
    Cancer Biol Ther; 2003; 2(1):63-6. PubMed ID: 12673119
    [No Abstract]   [Full Text] [Related]  

  • 28. The changing face of p53 in head and neck cancer.
    Partridge M; Costea DE; Huang X
    Int J Oral Maxillofac Surg; 2007 Dec; 36(12):1123-38. PubMed ID: 17875383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNp73 a matter of cancer: mechanisms and clinical implications.
    Buhlmann S; Pützer BM
    Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-family proteins and their regulators: hubs and spokes in tumor suppression.
    Collavin L; Lunardi A; Del Sal G
    Cell Death Differ; 2010 Jun; 17(6):901-11. PubMed ID: 20379196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Evolution and Dynamics of the p53 Proteins.
    Chillemi G; Kehrloesser S; Bernassola F; Desideri A; Dötsch V; Levine AJ; Melino G
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 27091942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p63, cellular senescence and tumor development.
    Guo X; Mills AA
    Cell Cycle; 2007 Feb; 6(3):305-11. PubMed ID: 17224650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p73 regulates maintenance of neural stem cell.
    Agostini M; Tucci P; Chen H; Knight RA; Bano D; Nicotera P; McKeon F; Melino G
    Biochem Biophys Res Commun; 2010 Dec; 403(1):13-7. PubMed ID: 20977890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the p53-family in cancer and chemosensitivity: triple threat.
    Chung J; Irwin MS
    Curr Drug Targets; 2010 Jun; 11(6):667-81. PubMed ID: 20298155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p53 family: prospect for cancer gene therapy.
    Zhang J; Chen X
    Cancer Biol Ther; 2007 Jan; 6(1):116-8. PubMed ID: 17612008
    [No Abstract]   [Full Text] [Related]  

  • 36. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways.
    McElhinny AS; Li JL; Wu L
    Oncogene; 2008 Sep; 27(38):5138-47. PubMed ID: 18758483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actin nucleation by a transcription co-factor that links cytoskeletal events with the p53 response.
    Coutts AS; Weston L; La Thangue NB
    Cell Cycle; 2010 Apr; 9(8):1511-5. PubMed ID: 20372063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of p53-target genes in human cancer.
    Tokino T; Nakamura Y
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):1-6. PubMed ID: 10714958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1.
    Qian Y; Jung YS; Chen X
    Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11300-5. PubMed ID: 22723347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why YPEL3 represents a novel tumor suppressor.
    Berberich SJ; Todd A; Tuttle R
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1746-51. PubMed ID: 21196260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.